🇺🇸 FDA

Intelligence · Clinical Pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs
1,839

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Page 26 of 39

  1. Ramelteon

    Takeda

    Schizophrenia

    approved small molecule completed

    1 trial

  2. Ramelteon

    Takeda

    Seasonal Affective Disorder

    approved small molecule completed

    1 trial

  3. Ramelteon

    Takeda

    ADHD With Sleep Onset Insomnia

    approved small molecule completed

    1 trial

  4. Ramelteon

    Takeda

    Insomnia

    approved small molecule completed

    6 trials

  5. Ramelteon

    Takeda

    Circadian Dysregulation

    approved small molecule completed

    1 trial

  6. Ramelteon

    Takeda

    Chronic Insomnia

    approved small molecule completed

    7 trials

  7. Ramelteon

    Takeda

    Bipolar Disorder

    approved small molecule terminated

    2 trials

  8. Ramelteon (RozeremR)

    Takeda

    Insomnia

    approved small molecule terminated

    1 trial

  9. Ramelteon and Placebo

    Takeda

    Chronic Obstructive Pulmonary Disease

    approved small molecule completed

    2 trials

  10. Ramelteon and zolpidem

    Takeda

    Chronic Insomnia

    approved small molecule completed

    1 trial

  11. Ramelteon, zolpidem and placebo

    Takeda

    Insomnia

    approved small molecule completed

    1 trial

  12. Ramosetron

    Astellas Pharma Inc

    Irritable Bowel Syndrome

    approved small molecule completed

    1 trial

  13. Rapamune 1 mg coated tablets, MYCOPHENOLATE MOFETIL

    The George Institute

    End-stage kidney disease in Type 1 diabetes, SIROLIMUS VERSUS MYCOPHENOLATE MOFETIL IN SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANTATION TO EVALUATE THE RISK OF HERNIA

    approved small molecule active

    1 trial

  14. Rapid Acting insulin with pre-treatment of rHuPH20

    HALOZYME THERAPEUTICS, INC.

    Type 1 Diabetes Mellitus

    approved small molecule completed

    1 trial

  15. Rapydan

    Jazz Pharmaceuticals Ireland Limited

    Healthy

    approved small molecule terminated

    1 trial

  16. Rasagiline

    Teva Pharma GmbH

    Sleep Disturbances

    approved small molecule completed

    1 trial

  17. Rasagiline

    Teva Pharma GmbH

    Depressive Symptoms

    approved small molecule completed

    1 trial

  18. Rasagiline

    Teva Pharma GmbH

    Parkinson's Disease

    approved small molecule active

    5 trials

  19. Rasagiline Mesylate

    Teva Pharma GmbH

    Parkinson's Disease

    approved small molecule completed

    8 trials

  20. Rasagiline/Placebo

    Teva Pharma GmbH

    Parkinson's Disease

    approved small molecule completed

    1 trial

  21. ReFacto

    Wyeth is now a wholly owned subsidiary of Pfizer

    Hemophilia A

    approved small molecule terminated

    1 trial

  22. Realgar-Indigo Naturalis Formulation Combined with Anlotinib

    The First People's Hospital of Lianyungang

    Platinum-resistant Ovarian Cancer (PROC)

    approved small molecule active

    1 trial

  23. Rebamipide

    Otsuka Beijing Research Institute

    Stomach Ulcer

    approved small molecule completed

    1 trial

  24. Rebamipide 2% ophthalmic solution

    Samsung Bioepis NL B.V.

    Dry Eye Disease (DED)

    approved small molecule active

    1 trial

  25. Recaticimab

    The First People's Hospital of Lianyungang

    STEMI - ST Elevation Myocardial Infarction

    approved small molecule active

    1 trial

  26. Recaticimab and Statin

    The First People's Hospital of Lianyungang

    Intracranial Atherosclerosis

    approved small molecule active

    1 trial

  27. Recigarum 1,5 mg comprimidos recubiertos con película EFG

    The George Institute

    Active smokers

    approved small molecule active

    1 trial

  28. Recombinant FSH (follitropin alpha)

    United Therapeutics Europe Ltd

    Ovulation Induction

    approved small molecule completed

    1 trial

  29. Recombinant Human Adenovirus Type 5 injection

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma

    approved small molecule active

    1 trial

  30. Recombinant Protein-Free Factor VIII (rAHF-PFM)

    Takeda

    Hemophilia A

    approved small molecule completed

    1 trial

  31. Recombinant Staphylokinase

    The First People's Hospital of Lianyungang

    Acute Myocardial Infarction

    approved small molecule completed

    1 trial

  32. Recombinant Staphylokinase

    The First People's Hospital of Lianyungang

    ST-segment Elevation Myocardial Infarction (STEMI)

    approved small molecule completed

    1 trial

  33. Recombinant human growth hormone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Achondroplasia

    approved small molecule active

    1 trial

  34. Recombinant human growth hormone (r-hGH)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Dwarfism, Pituitary

    approved small molecule completed

    1 trial

  35. Recombinant staphylokinase

    The First People's Hospital of Lianyungang

    ST Elevation Myocardial Infarction

    approved small molecule active

    1 trial

  36. Recombinant subunit B/bacterial cholera vaccine (enteric-coated capsules)

    United Therapeutics Europe Ltd

    Diarrhea

    approved mab active

    1 trial

  37. Recombinant tissue plasminogen activator (rt-PA)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pulmonary Thromboembolisms

    approved small molecule active

    1 trial

  38. Regadenoson

    Aspire Biopharma Holdings

    Coronary Artery Disease

    approved small molecule completed

    1 trial

  39. Regimen:TDF+3TC+EFV

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hiv

    approved small molecule completed

    1 trial

  40. Regimen：BIC+FTC+TAF

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HIV Infection

    approved small molecule active

    1 trial

  41. Regiocit solution pour hémofiltration

    Pari Pharma GmbH

    Adult patients hospitalized in intensive care with an indication of EER with ARC during the stay.

    approved small molecule active

    1 trial

  42. Regional Anesthesia

    BRIGHT MINDS BIOSCIENCES INC.

    Inguinal Hernia

    approved small molecule completed

    1 trial

  43. Reinforcement Based Treatment

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Abuse

    approved other completed

    1 trial

  44. Rematazolam Besylate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Emergence Agitation

    approved small molecule active

    1 trial

  45. Remifentanil

    Hospital Authority, Hong Kong

    Labor Pain

    approved small molecule active

    1 trial

  46. Remimazolam Besylate for Injection

    The First People's Hospital of Lianyungang

    Thoracic Surgery

    approved small molecule active

    1 trial

  47. Remodulin

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    approved small molecule completed

    1 trial

  48. Remsima 100 mg powder for concentrate for solution for infusion

    Disc Medicine

    Crohn's Disease

    approved small molecule active

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.